Dr. Gordon A. Brown, DO
Urology (Urology Physician)
- Medicare participating
At a glance
- Medical school
- Rutgers New Jersey Medical School (1998)
- Years since graduation
- 28
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 1,439
Licensed in Texas since 2004, according to the Texas Medical Board. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1998Medical school: Rutgers New Jersey Medical School
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Urology Physician primary
NJ license 25MB06991400 · TX license M0022 (first issued 2004; canc non-renewal)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Cooper University Hospital Camden, NJ
- West Jersey Hospital Voorhees, NJ
- Virtua Mount Holly Hospital Mount Holly, NJ
- Jefferson Stratford Hospital Stratford, NJ
- Inspira Medical Center Mullica Hill Elmer, NJ
Medical groups
- Summit Medical Group PA (1,212 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,439
- Services billed
- 14,378
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Injection, degarelix, 1 mg | 5,520 | 23 |
| Established patient office or other outpatient visit, 20-29 minutes | 1,775 | 969 |
| Established patient office or other outpatient visit, 30-39 minutes | 931 | 539 |
| Automated urinalysis test | 769 | 529 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 741 | 83 |
| Ultrasound measurement of bladder capacity after voiding | 338 | 257 |
| Bacterial urine culture | 245 | 178 |
| Bacterial colony count, urine | 245 | 178 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 160 | 92 |
| Diagnostic exam of bladder and urethra using an endoscope | 160 | 112 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Tamsulosin Hcl Other prescribers in Cherry Hill, NJ | 1,569 |
| Orgovyx (relugolix) | 389 |
| Abiraterone Acetate | 383 |
| Prednisone Other prescribers in Cherry Hill, NJ | 348 |
| Dutasteride Other prescribers in Cherry Hill, NJ | 254 |
| Nitrofurantoin Mono-Macro (nitrofurantoin monohyd/m-cryst) Other prescribers in Cherry Hill, NJ | 235 |
| Finasteride Other prescribers in Cherry Hill, NJ | 192 |
| Erleada (apalutamide) | 191 |
| Nubeqa (darolutamide) | 183 |
| Cefadroxil Other prescribers in Cherry Hill, NJ | 183 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 19 companies reported 188 payments worth $244,581 in total to this clinician.
| Janssen Biotech, Inc. | $75,530 |
|---|---|
| AstraZeneca Pharmaceuticals LP | $51,660 |
| Bayer HealthCare Pharmaceuticals Inc. | $28,646 |
| Astellas Pharma US Inc | $22,638 |
| Pfizer Inc. | $21,002 |
| Sumitomo Pharma America, Inc. | $18,965 |
| Novartis Pharmaceuticals Corporation | $8,294 |
| Janssen Scientific Affairs, LLC | $7,320 |
| Compensation for services other than consulting (speaking, faculty) | $164,249 |
|---|---|
| Consulting Fee | $45,590 |
| Travel and Lodging | $28,005 |
| Food and Beverage | $3,555 |
| Honoraria | $3,125 |
| Education | $57.05 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. Dec 10, 2025 | Compensation for services other than consulting (speaking, faculty) ORGOVYX · PROSTATE CANCER | $11,165 |
| Bayer HealthCare Pharmaceuticals Inc. Sep 4, 2025 | Compensation for services other than consulting (speaking, faculty) Nubeqa · Oncology | $5,586 |
| Sumitomo Pharma America, Inc. Feb 26, 2025 | Compensation for services other than consulting (speaking, faculty) ORGOVYX · PROSTATE CANCER | $5,525 |
| AstraZeneca Pharmaceuticals LP Mar 7, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $5,400 |
| AstraZeneca Pharmaceuticals LP May 12, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $5,400 |
| AstraZeneca Pharmaceuticals LP Oct 14, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $5,400 |
| AstraZeneca Pharmaceuticals LP Nov 3, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $5,400 |
| Janssen Scientific Affairs, LLC Nov 17, 2025 | Consulting Fee ERLEADA · Oncology | $5,000 |
| Astellas Pharma US Inc Nov 5, 2025 | Consulting Fee Xtandi · Oncology | $5,000 |
| Pfizer Inc. Dec 17, 2025 | Consulting Fee TALZENNA · ONCOLOGY | $5,000 |
All 125 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. Dec 18, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $1,280 |
| Pfizer Inc. Dec 17, 2025 | Consulting Fee TALZENNA · ONCOLOGY | $5,000 |
| Sumitomo Pharma America, Inc. Dec 10, 2025 | Compensation for services other than consulting (speaking, faculty) ORGOVYX · PROSTATE CANCER | $11,165 |
| Janssen Biotech, Inc. Dec 5, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $1,280 |
| Bayer HealthCare Pharmaceuticals Inc. Nov 26, 2025 | Compensation for services other than consulting (speaking, faculty) Nubeqa · Oncology | $3,234 |
| Janssen Scientific Affairs, LLC Nov 24, 2025 | Consulting Fee ERLEADA · Oncology | $2,175 |
| Janssen Scientific Affairs, LLC Nov 17, 2025 | Consulting Fee ERLEADA · Oncology | $5,000 |
| Pfizer Inc. Nov 17, 2025 | Consulting Fee | $700 |
| Urogen Pharma, Inc. Nov 14, 2025 | Honoraria ZUSDURI · LG-IR-NMIBC | $3,125 |
| AstraZeneca Pharmaceuticals LP Nov 13, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $4,050 |
| AstraZeneca Pharmaceuticals LP Nov 12, 2025 | Consulting Fee IMFINZI · Oncology | $1,350 |
| AstraZeneca Pharmaceuticals LP Nov 11, 2025 | Travel and Lodging travel to West Chester, PA · in-kind Company’s descriptionSpeaker Expenses | $637 |
| Bayer HealthCare Pharmaceuticals Inc. Nov 7, 2025 | Compensation for services other than consulting (speaking, faculty) Nubeqa · Oncology | $3,234 |
| Astellas Pharma US Inc Nov 5, 2025 | Consulting Fee Xtandi · Oncology | $5,000 |
| AstraZeneca Pharmaceuticals LP Nov 3, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $5,400 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 28, 2025 | Travel and Lodging Nubeqa · Oncology · travel to Reading, PA · in-kind | $918 |
| AstraZeneca Pharmaceuticals LP Oct 28, 2025 | Travel and Lodging travel to Short Hills, NJ · in-kind Company’s descriptionSpeaker Expenses | $784 |
| AstraZeneca Pharmaceuticals LP Oct 14, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $5,400 |
| AstraZeneca Pharmaceuticals LP Oct 10, 2025 | Travel and Lodging LYNPARZA · Oncology · travel to National Harbor, MD · in-kind Company’s descriptionSpeaker Expenses | $1,845 |
| AstraZeneca Pharmaceuticals LP Oct 10, 2025 | Travel and Lodging LYNPARZA · Oncology · travel to National Harbor, MD · in-kind Company’s descriptionSpeaker Expenses | $382 |
| AstraZeneca Pharmaceuticals LP Oct 9, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $4,050 |
| AstraZeneca Pharmaceuticals LP Oct 7, 2025 | Travel and Lodging travel to Toms River, NJ · in-kind Company’s descriptionSpeaker Expenses | $733 |
| Bayer HealthCare Pharmaceuticals Inc. Oct 4, 2025 | Compensation for services other than consulting (speaking, faculty) Nubeqa · Oncology | $4,704 |
| AstraZeneca Pharmaceuticals LP Oct 2, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $1,350 |
| Bayer HealthCare Pharmaceuticals Inc. Sep 26, 2025 | Travel and Lodging Nubeqa · Oncology · travel to Sandy Springs, GA · in-kind | $593 |
| Janssen Biotech, Inc. Sep 19, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $4,800 |
| Bayer HealthCare Pharmaceuticals Inc. Sep 15, 2025 | Travel and Lodging Nubeqa · Oncology · travel to Somerville, NJ · in-kind | $839 |
| Janssen Biotech, Inc. Sep 12, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Boston, MA · in-kind | $116 |
| Bayer HealthCare Pharmaceuticals Inc. Sep 11, 2025 | Travel and Lodging Nubeqa · Oncology · travel to Sandy Springs, GA · in-kind | $917 |
| Astellas Pharma US Inc Sep 8, 2025 | Compensation for services other than consulting (speaking, faculty) Xtandi · Oncology | $3,900 |
| Astellas Pharma US Inc Sep 8, 2025 | Travel and Lodging Xtandi · Oncology · travel to Syracuse, NY | $1,514 |
| Astellas Pharma US Inc Sep 8, 2025 | Travel and Lodging Xtandi · Oncology · travel to Syracuse, NY | $474 |
| Janssen Biotech, Inc. Sep 8, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Boston, MA · in-kind | $178 |
| Janssen Biotech, Inc. Sep 7, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Boston, MA · in-kind | $0.01 |
| Astellas Pharma US Inc Sep 5, 2025 | Compensation for services other than consulting (speaking, faculty) Xtandi · Oncology | $3,900 |
| Astellas Pharma US Inc Sep 5, 2025 | Travel and Lodging Xtandi · Oncology · travel to Boston, MA | $413 |
| Bayer HealthCare Pharmaceuticals Inc. Sep 4, 2025 | Compensation for services other than consulting (speaking, faculty) Nubeqa · Oncology | $5,586 |
| Janssen Biotech, Inc. Sep 4, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Boston, MA · in-kind | $296 |
| Pfizer Inc. Sep 2, 2025 | Consulting Fee | $1,400 |
| Pfizer Inc. Sep 2, 2025 | Consulting Fee | $700 |
| Bayer HealthCare Pharmaceuticals Inc. Aug 22, 2025 | Travel and Lodging Nubeqa · Oncology · travel to Myrtle Beach,, SC · in-kind | $969 |
| Bayer HealthCare Pharmaceuticals Inc. Aug 19, 2025 | Travel and Lodging Nubeqa · Oncology · travel to Myrtle Beach,, SC · in-kind | $247 |
| Bayer HealthCare Pharmaceuticals Inc. Aug 7, 2025 | Travel and Lodging Nubeqa · Oncology · travel to Myrtle Beach,, SC · in-kind | $759 |
| Janssen Biotech, Inc. Aug 5, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Boston, MA · in-kind | $5.50 |
| Janssen Biotech, Inc. Aug 4, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Boston, MA · in-kind | $333 |
| Bayer HealthCare Pharmaceuticals Inc. Jun 27, 2025 | Compensation for services other than consulting (speaking, faculty) Nubeqa · Oncology | $1,176 |
| Astellas Pharma US Inc Jun 26, 2025 | Compensation for services other than consulting (speaking, faculty) Xtandi · Oncology | $3,250 |
| Novartis Pharmaceuticals Corporation Jun 16, 2025 | Consulting Fee | $2,700 |
| AstraZeneca Pharmaceuticals LP Jun 4, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $3,375 |
| AstraZeneca Pharmaceuticals LP Jun 4, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $2,025 |
| Janssen Biotech, Inc. May 29, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $800 |
| Janssen Biotech, Inc. May 28, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $800 |
| AstraZeneca Pharmaceuticals LP May 28, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $300 |
| AstraZeneca Pharmaceuticals LP May 22, 2025 | Travel and Lodging travel to WILMINGTON, DE · in-kind Company’s descriptionSpeaker Expenses | $1,049 |
| Janssen Biotech, Inc. May 22, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $640 |
| Pfizer Inc. May 20, 2025 | Consulting Fee | $4,625 |
| Janssen Biotech, Inc. May 16, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $4,800 |
| Dendreon Pharmaceuticals LLC May 16, 2025 | Compensation for services other than consulting (speaking, faculty) PROVENGE · CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | $1,580 |
| Janssen Biotech, Inc. May 16, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $640 |
| Astellas Pharma US Inc May 15, 2025 | Consulting Fee Padcev · Oncology | $3,850 |
| Novartis Pharmaceuticals Corporation May 15, 2025 | Consulting Fee | $675 |
| Janssen Biotech, Inc. May 15, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Detroit, MI · in-kind | $321 |
| AstraZeneca Pharmaceuticals LP May 12, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $5,400 |
| Ferring Pharmaceuticals Inc. May 12, 2025 | Consulting Fee ADSTILADRIN · ONCOLOGY | $2,850 |
| Pfizer Inc. May 10, 2025 | Travel and Lodging travel to New York, NY · in-kind | $1,228 |
| Janssen Biotech, Inc. May 9, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $4,800 |
| Janssen Biotech, Inc. May 9, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Miami, FL · in-kind | $501 |
| Janssen Biotech, Inc. May 7, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $1,280 |
| Janssen Biotech, Inc. May 6, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $1,280 |
| Novartis Pharmaceuticals Corporation May 6, 2025 | Consulting Fee | $675 |
| Janssen Global Services, LLC Apr 26, 2025 | Consulting Fee | $1,150 |
| Janssen Biotech, Inc. Apr 24, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Detroit, MI · in-kind | $596 |
| Janssen Biotech, Inc. Apr 21, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $1,280 |
| Pfizer Inc. Apr 16, 2025 | Consulting Fee TALZENNA · ONCOLOGY | $700 |
| Janssen Biotech, Inc. Apr 15, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Miami, FL · in-kind | $648 |
| Janssen Biotech, Inc. Apr 14, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $4,800 |
| Janssen Biotech, Inc. Apr 11, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $4,800 |
| Janssen Biotech, Inc. Apr 10, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to New York, NY · in-kind | $859 |
| AstraZeneca Pharmaceuticals LP Apr 10, 2025 | Compensation for services other than consulting (speaking, faculty)Company’s descriptionSpeaker Fee | $300 |
| Janssen Biotech, Inc. Apr 9, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $1,280 |
| Janssen Biotech, Inc. Apr 9, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Atlanta, GA · in-kind | $385 |
| Janssen Biotech, Inc. Apr 7, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $1,280 |
| Janssen Biotech, Inc. Apr 3, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $4,800 |
| Bayer HealthCare Pharmaceuticals Inc. Apr 2, 2025 | Compensation for services other than consulting (speaking, faculty) Nubeqa · Oncology | $3,822 |
| Janssen Biotech, Inc. Apr 2, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Roslyn, NY · in-kind | $1,096 |
| Janssen Biotech, Inc. Apr 1, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $4,160 |
| Janssen Biotech, Inc. Apr 1, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $2,012 |
| Janssen Biotech, Inc. Apr 1, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $2,012 |
| Janssen Biotech, Inc. Apr 1, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $2,012 |
| Janssen Biotech, Inc. Apr 1, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $2,012 |
| Bayer HealthCare Pharmaceuticals Inc. Mar 29, 2025 | Travel and Lodging Nubeqa · Oncology · travel to Rehoboth Beach, DE · in-kind | $1,170 |
| Janssen Biotech, Inc. Mar 28, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $4,800 |
| Janssen Biotech, Inc. Mar 27, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Atlanta, GA · in-kind | $5.50 |
| Janssen Biotech, Inc. Mar 26, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Atlanta, GA · in-kind | $612 |
| Novartis Pharmaceuticals Corporation Mar 22, 2025 | Consulting Fee | $3,200 |
| Novartis Pharmaceuticals Corporation Mar 22, 2025 | Travel and Lodging travel to EAST HANOVER, NJ | $972 |
| Janssen Biotech, Inc. Mar 21, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Ambler, PA · in-kind | $240 |
| Janssen Biotech, Inc. Mar 19, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Wall Township, NJ · in-kind | $535 |
| Janssen Biotech, Inc. Mar 19, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Ambler, PA · in-kind | $208 |
| Janssen Biotech, Inc. Mar 17, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Roslyn, NY · in-kind | $5.50 |
| Janssen Biotech, Inc. Mar 14, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to New York, NY · in-kind | $5.50 |
| AstraZeneca Pharmaceuticals LP Mar 13, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $4,050 |
| Janssen Biotech, Inc. Mar 13, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Wall Township, NJ · in-kind | $5.50 |
| Sumitomo Pharma America, Inc. Mar 12, 2025 | Compensation for services other than consulting (speaking, faculty) ORGOVYX · PROSTATE CANCER | $2,275 |
| AstraZeneca Pharmaceuticals LP Mar 11, 2025 | Travel and Lodging LYNPARZA · Oncology · travel to Bay Head, NJ · in-kind Company’s descriptionSpeaker Expenses | $635 |
| AstraZeneca Pharmaceuticals LP Mar 7, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $5,400 |
| Janssen Biotech, Inc. Mar 6, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $4,800 |
| Janssen Biotech, Inc. Mar 6, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Virginia Beach, VA · in-kind | $44.00 |
| AstraZeneca Pharmaceuticals LP Mar 5, 2025 | Compensation for services other than consulting (speaking, faculty) LYNPARZA · Oncology Company’s descriptionSpeaker Fee | $1,350 |
| Dendreon Pharmaceuticals LLC Mar 5, 2025 | Compensation for services other than consulting (speaking, faculty) PROVENGE · CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | $1,185 |
| Janssen Biotech, Inc. Mar 5, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Morristown, NJ · in-kind | $616 |
| Janssen Biotech, Inc. Mar 3, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Ambler, PA · in-kind | $5.50 |
| Janssen Biotech, Inc. Feb 28, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Morristown, NJ · in-kind | $5.50 |
| AstraZeneca Pharmaceuticals LP Feb 27, 2025 | Travel and Lodging LYNPARZA · Oncology · travel to Roslyn, NY · in-kind Company’s descriptionSpeaker Expenses | $1,016 |
| Sumitomo Pharma America, Inc. Feb 26, 2025 | Compensation for services other than consulting (speaking, faculty) ORGOVYX · PROSTATE CANCER | $5,525 |
| Janssen Biotech, Inc. Feb 26, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Virginia Beach, VA · in-kind | $1,697 |
| Bayer HealthCare Pharmaceuticals Inc. Feb 26, 2025 | Education Nubeqa · Oncology · in-kind | $57.05 |
| Janssen Biotech, Inc. Feb 25, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $833 |
| Janssen Biotech, Inc. Feb 24, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $833 |
| Janssen Biotech, Inc. Feb 11, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Virginia Beach, VA · in-kind | $5.50 |
| Janssen Biotech, Inc. Feb 10, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Virginia Beach, VA · in-kind | $390 |
| Janssen Biotech, Inc. Feb 5, 2025 | Compensation for services other than consulting (speaking, faculty) RYBREVANT; CARVYKTI · Oncology | $550 |
| Janssen Biotech, Inc. Jan 30, 2025 | Travel and Lodging RYBREVANT; CARVYKTI · Oncology · travel to Virginia Beach, VA · in-kind | $195 |
| Pfizer Inc. Jan 15, 2025 | Compensation for services other than consulting (speaking, faculty) | $2,600 |
| Pfizer Inc. Jan 13, 2025 | Consulting Fee PADCEV · ONCOLOGY | $3,840 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 4 industry-funded studies in 2025, from 4 companies. The companies reported $97,582 in research payments for these studies, mostly to the institutions running them.
- A Multi-Center, Prospective, Observational Study of Patients Being Treated With ORGOVYX
Sumitomo Pharma America, Inc. · Completed · NCT05467176 - BAY 1841788, Open-label study of Androgen Receptor Inhibition with dArolutamide plus Androgen Deprivation Therapy (ADT) Versus ADT in men with Metastatic Hormone-Sensitive Prostate Cancer not planned
Bayer HealthCare Pharmaceuticals Inc. - A randomized,double blind,placebo controlled,phase third study of adjuvant saruparib AZD5305 in patients with bracam localized high risk prostate cancer receiving radiotherapy with aqndrogen deprivation therapy evo p…
AstraZeneca UK Limited - A Phase III, Open-label, Multi-center, Randomized Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive Metastatic Castration Resistant Prostate Cancer
Novartis Pharmaceuticals Corporation
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.